Cargando…

SAT-291 Gonadotropin Releasing Hormone Agonist Therapy Improves Hyperandrogenism in an Adolescent with Type A Insulin Resistance Syndrome

Background: Type A insulin resistance (IR) is a form of severe IR due to heterozygous mutations in the insulin receptor gene. It presents with acanthosis nigricans, IR, and hyperandrogenism in the absence of obesity or lipodystrophy. Treatment aims to decrease androgens and improve insulin sensitivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paprocki, Emily, Barral, Romina, Burgert, Tania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552534/ http://dx.doi.org/10.1210/js.2019-SAT-291

Ejemplares similares

GnRH Agonist Improves Hyperandrogenism in an Adolescent Girl With an Insulin Receptor Gene Mutation
por: Paprocki, Emily, et al.
Publicado: (2019)

SAT-304 Unexplained Asymptomatic Hyperestrogenism in Central Precocious Puberty Patient Treated with Gonadotropin Releasing Hormone Agonist
por: Kim, Dae Hyun, et al.
Publicado: (2019)

SAT352 Reliability Of Two- And Three-dimensional Ultrasonographic Assessments Of Ovarian Morphology In Adolescents
por: Rahman, Effat, et al.
Publicado: (2023)

SAT-303 Combined Treatment of Gonadotropin Releasing Hormone Agonist and Recombinant Human Growth Hormone in Cental Precocious Puberty Patient with Underlying Leri Weill Dyschondrosteosis
por: Choi, Ju-hee, et al.
Publicado: (2019)

SAT-307 Sudden Unexpected Vaginal Bleeding Caused by Temporal Reactivation of Hypothalamic-Hypophyseal-Gonadal Axis during Gonadotropin Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Kim, Dae Hyun, et al.
Publicado: (2019)

Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance
por: Huang-Doran, Isabel, et al.
Publicado: (2021)

MON-241 Relationship between Final Height and Birth Weight after Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Central Precocious Puberty
por: Kim, Eun Young, et al.
Publicado: (2019)

MON-243 The Difference of Body Mass Index Score before and after Gonadotropin-Releasing Hormone Agonist Treatment in Cerntral Precocious Puberty Girls
por: Choi, Yujung, et al.
Publicado: (2019)

SAT376 Luteinizing Hormone Secretion in Hyperandrogenic Girls Taking Spironolactone or Metformin
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2023)

Primary Amenorrhea and Hyperandrogenism: Presenting Features of a Growth Hormone Producing Pituitary Adenoma in a Female Adolescent
por: Verma, Arushi, et al.
Publicado: (2021)

Transient Arterial Hypertension Induced by Gonadotropin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Sifaki, Loukia, et al.
Publicado: (2019)

SUN-267 Relationship between Height Velocity and Change of Serum Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Concentrations during Gonadotropin-Releasing Hormone Agonist Treatment in Korean Girls with Idiopathic Central Precocious Puberty
por: Yang, Seung, et al.
Publicado: (2019)

LBODP081 The Relationship Between Body Mass Index Changes And Bone Age Progression During Gonadotropin-releasing Hormone Agonist Treatment In Girls With Idiopathic Central Precocious Puberty
por: Kim, Seulki, et al.
Publicado: (2022)

SAT-245 Estimated Insulin Sensitivity Score Predicts Post-OSTT Insulin Secretion and GI Hormone Differences in Adolescents with Obesity and PCOS
por: Garcia Reyes, Yesenia, et al.
Publicado: (2019)

THU194 Growth Pattern And Related Predictors Of Gonadotropin-releasing Hormone Analog Treatment In Girls With Precocious Puberty
por: Ouyang, Lixue, et al.
Publicado: (2023)

Hormonal profile in early luteal phase after triggering ovulation with gonadotropin-releasing hormone agonist in high-responder patients
por: Martazanova, Bella, et al.
Publicado: (2022)

The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty
por: Tseng, Chin-Hui, et al.
Publicado: (2023)

SAT360 Ovarian Vein Sampling in a Pre-menopausal Woman with Hyperandrogenism: Characterization of Hormonal Profiles
por: Hu, Tina Y, et al.
Publicado: (2023)

Epigenetic Control of Gonadotropin Releasing Hormone Neurons
por: Kurian, Joseph R., et al.
Publicado: (2013)

PMON313 Hyperinsulinemic Hypoglycemia and Growth Hormone Deficiency Secondary to 20p11 Deletion
por: Wee, Erica, et al.
Publicado: (2022)

Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism
por: Tng, Eng-Loon, et al.
Publicado: (2020)

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study
por: Drakopoulos, Panagiotis, et al.
Publicado: (2019)

Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist
por: Ji, Hui, et al.
Publicado: (2022)

Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
por: Merkison, Jamie, et al.
Publicado: (2022)

MON-LB051 Non-inferiority Clinical Trial on Gonadotropinversus Pulsatile Gonadotropin-releasing Hormone Infusion Therapy in Male Adolescent Patient with Congenital Hypogonadotropic Hypogonadism
por: Liu, Ying
Publicado: (2019)

ODP420 Ovarian Venous Sampling and the Diagnostic Challenges Associated with Identifying the Source of Severe Hyperandrogenism in an Adolescent Female
por: Halpin, Kelsee, et al.
Publicado: (2022)

Editorial: Gonadotropin-Releasing Hormone Receptor Signaling and Functions
por: Bjelobaba, Ivana, et al.
Publicado: (2018)

Semaphorin Signaling in the Development and Function of the Gonadotropin Hormone-Releasing Hormone System
por: Messina, Andrea, et al.
Publicado: (2013)

SAT364 A Rare Cause of Hyperandrogenism in a Premenopausal Woman
por: Musa Penna, Laurianne El, et al.
Publicado: (2023)

SAT-106 Growth Hormone Treatment Response in Children
por: Rath, Mitchell, et al.
Publicado: (2020)

Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
por: Lawrenz, Barbara, et al.
Publicado: (2018)

Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System
por: Ohlsson, Bodil
Publicado: (2017)

The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
por: Gründker, Carsten, et al.
Publicado: (2017)

Invertebrate Gonadotropin-Releasing Hormone-Related Peptides and Their Receptors: An Update
por: Sakai, Tsubasa, et al.
Publicado: (2017)

SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
por: Chavez, Luis, et al.
Publicado: (2019)

SUN-291 17 Year Old Male with Galactorrhea and Elevations in Prolactin and ACTH in the Setting of a Pituitary Microadenoma
por: Nasir, Hamza, et al.
Publicado: (2019)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

SAT-108 Growth Hormone Deficiency in a Patient with Ectodermal Dysplasia
por: Alkhaled, Lina, et al.
Publicado: (2020)

Early Development of the Gonadotropin-Releasing Hormone Neuronal Network in Transgenic Zebrafish
por: Zhao, Yali, et al.
Publicado: (2013)

Expression and Role of Gonadotropin-Releasing Hormone 2 and Its Receptor in Mammals
por: Desaulniers, Amy T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_558kh8tnuoijm8junjrsnt2h22